Brought together

The innovative pharmaceutical industry in the UK exists to transform and improve lives through research, development and access to new medicines and vaccines.

Pharmaceutical companies work in partnership with the NHS, academia and government to bring the latest medicines and vaccines to patients to improve their health and quality of life.

Recent improvements to the way in which the UK values innovative medicines mark the beginning of a new chapter for UK medicines research, investment and access to treatment. The long-overdue changes aim to address a decade of underinvestment in NHS medicines, helping to improve patient care, strengthen the NHS, and deliver better health outcomes for everyone.

Find out more about what’s needed to bring research investment and new medicines to the whole of the UK by exploring the sections below.

Access

667922 ABPI Valueofindustry Access

Read more about how innovative medicines and NHS patients have been kept apart.

Uptake

667922 ABPI Valueofindustry Uptake

Read more about how medicines and the nation's health have been kept apart

Research

667922 ABPI Valueofindustry Research

Read more about how medicines research and NHS patients have been kept apart